Valuation : Hikma Pharmaceuticals PLC

Market Cap 4.65B 4.01B 3.76B 3.43B 6.47B 445B 6.49B 44.61B 17.41B 225B 17.47B 17.09B 745B P/E 2026 *
12x
P/E 2027 * 10.7x
Enterprise Value 6.12B 5.28B 4.95B 4.52B 8.51B 585B 8.53B 58.69B 22.9B 295B 22.99B 22.49B 979B EV / Sales 2026 *
1.77x
EV / Sales 2027 * 1.65x
Free-Float
63.17%
Yield 2026 *
3.9%
Yield 2027 * 4.13%
1 day-0.46%
1 week-0.49%
Current month+1.96%
1 month+2.47%
3 months+8.09%
6 months+22.98%
Current year+4.26%
1 week 1,609
Extreme 1609
1,648
1 month 1,563
Extreme 1563
1,755
Current year 1,187
Extreme 1187
1,762
1 year 1,187
Extreme 1187
1,865
3 years 1,187
Extreme 1187
2,360
5 years 1,174.5
Extreme 1174.5
2,625
10 years 814.2
Extreme 814.2
2,768
Manager TitleAgeSince
Chief Executive Officer 69 2025-11-30
Director of Finance/CFO - 2026-02-25
Chief Tech/Sci/R&D Officer 64 2026-02-25
Director TitleAgeSince
Director/Board Member 69 2005-10-13
Director/Board Member 54 2025-12-14
Chairman 69 2014-05-14
Date Insider Type Main position Quantity % Market Cap.
6/1/26 Sell

Investor Relations Manager

-26,558 0.0124%
6/1/26 Fiscal year

Director

72,763 0.0339%
6/1/26 Fiscal year

Director

20,650 0.0096%
Change 5-day change 1-year change 3-year change Capi.($)
-0.74%-0.49%-12.32%-23.85% 4.65B
-0.13%-6.44%+60.47%+112.05% 1,048B
+0.85%-0.81%+52.77%+63.15% 640B
-1.03%-3.58%+22.87%+73.29% 456B
-1.46%-3.52%+36.60%+38.39% 362B
-0.72%-2.06%+21.34%+37.92% 295B
-1.19%-0.98%+0.79%+12.29% 255B
-1.05%-1.57%+51.40%+68.55% 236B
+0.08%-0.22%-17.16%-53.76% 204B
-2.14%-0.30%+29.42%+89.10% 185B
Average -0.63%-0.62%+24.62%+41.71% 368.63B
Weighted average by Cap. -0.44%-1.92%+38.36%+65.42%

Financials

2026 *2027 *
Net sales 3.46B 2.98B 2.8B 2.55B 4.81B 331B 4.83B 33.19B 12.95B 167B 13B 12.72B 554B 3.6B 3.1B 2.91B 2.66B 5B 344B 5.02B 34.53B 13.47B 174B 13.52B 13.23B 576B
Net income 412M 355M 333M 304M 573M 39.4B 575M 3.95B 1.54B 19.89B 1.55B 1.51B 65.94B 453M 391M 366M 334M 630M 43.34B 632M 4.35B 1.7B 21.88B 1.7B 1.67B 72.54B
Net Debt 1.47B 1.27B 1.19B 1.08B 2.04B 140B 2.05B 14.08B 5.49B 70.86B 5.51B 5.39B 235B 1.29B 1.11B 1.05B 954M 1.8B 124B 1.8B 12.4B 4.84B 62.4B 4.86B 4.75B 207B
Logo Hikma Pharmaceuticals PLC
Hikma Pharmaceuticals PLC is a multinational pharmaceutical company engaged in the development, manufacturing and marketing of a broad range of generic, branded and specialty pharmaceutical products. Its pharmaceutical operations are conducted through three business segments: Injectables, Branded and Hikma Rx. It supplies hospitals across North America, Europe and the Middle East and North Africa (MENA) region with generic injectable and specialty medicines, supported by its growing global manufacturing network. It supplies branded generic and in-licensed products from its local manufacturing facilities to retail and hospital customers across the MENA region. Through Hikma Rx, it supplies oral, respiratory and other generic and specialty products to the North American market. Its manufacturing facilities in the United States (US) supply products across a broad range of therapeutic areas, including respiratory, oncology and pain management, serving customers in both the US and Canada.
Employees
9,500
Date Price Change Volume
26-08-28 GBX 1,616.00 -0.74% 436,178
26-08-27 GBX 1,628.00 -0.73% 445,434
26-08-26 GBX 1,640.00 0.00% 862,660
26-08-25 GBX 1,640.00 +0.43% 349,026
26-08-24 GBX 1,633.00 -0.18% 680,937
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
22.12USD
Average target price
25.78USD
Spread / Average Target
+16.53%

Quarterly revenue - Rate of surprise